Short Interest in Kenvue Inc. (NYSE:KVUE) Declines By 34.1%

Kenvue Inc. (NYSE:KVUE - Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 32,460,000 shares, a decrease of 34.1% from the May 15th total of 49,270,000 shares. Approximately 1.7% of the company's stock are sold short. Based on an average daily volume of 18,130,000 shares, the short-interest ratio is currently 1.8 days.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on KVUE shares. Barclays upped their price target on Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Monday, May 12th. Evercore ISI assumed coverage on Kenvue in a research note on Monday, March 24th. They set an "in-line" rating and a $25.00 target price for the company. Citigroup reissued a "neutral" rating on shares of Kenvue in a report on Friday. Piper Sandler upped their price target on shares of Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research note on Monday, February 24th. Finally, Redburn Atlantic initiated coverage on shares of Kenvue in a research report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price target on the stock. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $25.33.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $21.65 on Tuesday. The firm has a 50 day moving average of $23.03 and a 200-day moving average of $22.48. Kenvue has a 12 month low of $17.67 and a 12 month high of $25.17. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $41.53 billion, a PE ratio of 40.84, a PEG ratio of 2.62 and a beta of 0.98.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The business had revenue of $3.74 billion for the quarter, compared to analysts' expectations of $3.69 billion. During the same period last year, the firm posted $0.28 earnings per share. The firm's quarterly revenue was down 3.9% compared to the same quarter last year. On average, equities research analysts predict that Kenvue will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were given a dividend of $0.205 per share. The ex-dividend date of this dividend was Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.79%. Kenvue's dividend payout ratio is currently 149.09%.

Institutional Trading of Kenvue

Large investors have recently bought and sold shares of the business. Evergreen Wealth Solutions LLC lifted its stake in shares of Kenvue by 2.6% in the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock valued at $402,000 after acquiring an additional 432 shares during the last quarter. Fulton Bank N.A. increased its holdings in Kenvue by 0.6% in the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after purchasing an additional 465 shares in the last quarter. Scott & Selber Inc. raised its position in Kenvue by 0.4% in the first quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after purchasing an additional 475 shares during the last quarter. Wealth Alliance LLC boosted its stake in shares of Kenvue by 1.6% during the first quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock valued at $762,000 after purchasing an additional 486 shares in the last quarter. Finally, Everett Harris & Co. CA grew its holdings in shares of Kenvue by 1.4% during the first quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock worth $887,000 after purchasing an additional 500 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.